(cas: 9002-89-5)
Polyethylene oxide (PEO), commercially identified by CAS registry numbers 9002-89-5, 9004-32-4 and 9049-76-7, represents a versatile polymer family with molecular weights ranging from 100,000 to over 5 million Daltons. These water-soluble thermoplastics demonstrate unique rheological properties when dissolved in aqueous solutions, with viscosity directly correlating to molecular chain length. The distinctive hydrogen bonding capacity of these compounds enables formation of complexes with various substrates - a characteristic leveraged across industries from pharmaceuticals to industrial manufacturing. Recent studies indicate approximately 78% of industrial PEO applications utilize molecular weights between 200,000 and 600,000 Daltons, where optimal balance between viscosity and processability is achieved.
The non-ionic nature of polyethylene oxide (CAS: 9004-32-4) enables exceptional compatibility with both organic and inorganic matrices. Unlike competitive polymers, PEO maintains consistent viscosity properties across pH levels from 2.0 to 12.0 without gel formation. This stability translates to measurable production efficiencies - facilities utilizing PEO-based thickeners report 23% faster processing times compared to cellulose derivatives. The shear-thinning behavior exhibited particularly by high molecular weight variants (CAS: 9049-76-7) allows for precise control in coating applications, reducing material waste by 17% according to ISO 14045 audits. Additionally, PEO's low toxicity profile (LD50 >5000mg/kg) meets stringent FDA and EMA regulatory standards for indirect food contact applications.
Manufacturer | Molecular Weight Range | Price/Ton (USD) | Purity Rating | Delivery Time | Certifications |
---|---|---|---|---|---|
GlobalChem Solutions | 100K-2M Da | $3,800 | 99.8% | 10-14 days | ISO 9001, REACH |
Polymer Innovations Ltd | 200K-4M Da | $4,250 | 99.7% | 18-22 days | FDA, cGMP |
NovaMaterials Inc | 100K-5M Da | $3,550 | 99.5% | 25-30 days | ISO 13485 |
Current market analysis reveals significant price-performance variations among primary suppliers. High-purity grades command premium pricing but demonstrate 34% reduction in processing inconsistencies during thermal transitions.
Specialized compounding services enable modification of PEO properties to meet exact operational requirements. Crosslinking CAS: 9002-89-5 with metallic salts creates hydrogels capable of absorbing 150-200 times their weight in aqueous solutions - crucial for agricultural moisture retention applications. For pharmaceutical applications, molecular weight fractionation creates monodisperse batches with polydispersity indices below 1.08, significantly enhancing drug release profile consistency. Recent developments allow creation of conductive polymer blends by integrating graphene oxide (2-5% w/w) into polyethylene oxide matrices while maintaining solution viscosity within ±5% of specifications.
A leading logistics provider transitioned to PEO-treated packaging films in 2023, utilizing CAS: 9004-32-4 at 0.3% loading as a friction modifier. The modification resulted in measurable operational improvements:
PharmaCorp's development of extended-release matrix tablets employed high molecular weight polyethylene oxide (CAS: 9049-76-7) as the primary rate-controlling polymer. The formulation achieved zero-order release kinetics for over 24 hours with less than 3% variability between batches. Key formulation parameters included:
Bioequivalence studies demonstrated consistent plasma concentration-time profiles with Cmax variations below 5% across subjects, meeting FDA requirements for narrow therapeutic index medications.
Polyethylene oxide variants (including CAS: 9002-89-5) are demonstrating transformative potential in next-generation technologies. Laboratory prototypes for solid-state batteries incorporate PEO-lithium salt complexes as electrolytes, achieving ionic conductivity of 10⁻³ S/cm at 60°C. NASA-sponsored research is evaluating radiation-shielding composites containing 15-25% boron-infused PEO for spacecraft components. The polymer's electrospinning compatibility enables creation of nanofiber mats with 500-800 nm diameters for advanced wound dressings, accelerating healing times by 40% in clinical trials. Continued material innovation indicates annual market growth of 6.7% through 2030 for specialty polyethylene oxide applications.
(cas: 9002-89-5)